Norway· NO-ID_53A1FCE6-4B19-420F-A9CB-AA99663A0F89
Ezmekly
A mirdametinib product containing mirdametinib, registered in Norway by Merck Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Mirdametinib is registered in 11 of 19 countries.
Countries holding a registration under ATC L01EE05 (mirdametinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Mirdametinib · ATC L01EE05
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Spainprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Mirdametinib
- Manufacturer
- Merck Europe B.V.
- Country
- Norway (NO)
- ATC code
- L01EE05
- ATC class
- Mirdametinib
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_53A1FCE6-4B19-420F-A9CB-AA99663A0F89
- gtin4150198721518
- no_varenummer56210442NOK 153307.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirdametinib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGomekliSpringWorks Therapeutics, Inc.
- CzechiaEZMEKLYMerck Europe B.V., Amsterdam
- SwitzerlandEzmekly
- BelgiumEzmekly 2 mgMerck Europe
- IcelandEzmeklyMerck Europe B.V.*
- NetherlandsEzmekly 2 mg harde capsulesMerck Europe B.V.
- PolandEzmeklySpringWorks Therapeutics Ireland Limited
- SwedenEzmekly 2 mg Kapsel, hårdMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Ezmekly
- Liechtenstein · Ezmekly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/abe341df-540b-42e1-94cc-74e25c8351e2 GET /v1/drugs/abe341df-540b-42e1-94cc-74e25c8351e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Mirdametinib",
"merkevare_id": "ID_53A1FCE6-4B19-420F-A9CB-AA99663A0F89",
"name_form_strength": "Ezmekly kaps 2 mg",
"prescription_group": "C"
}See everything about mirdametinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.